Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Presentation TCT 2025

A Prospective, Randomized Clinical Trial of Hemodynamic Support with a Newly Developed pVAD Versus IABP in Patients Undergoing High-Risk Percutaneous Coronary Intervention

Presenter: Rui Wang

October 28, 2025

Presentation TCT 2025

Perspective 1: IABP: Not Dead Yet

Presenter: Guy Witberg

October 28, 2025

Presentation TCT 2025

TCT 282: Clinical Characteristics and Outcome in IABP-Supported Cardiogenic Shock Among Patients Transferred to Tertiary Care Centers

Presenter: Jonas Sundermeyer

October 27, 2025

Presentation TCT 2025

TCT 968: Impella vs. IABP in High-Risk PCI Without Cardiogenic Shock: A Systematic Review and Meta-Analysis of Clinical Outcomes

Presenter: AHMED K. ABDELRAHMAN

October 27, 2025

Presentation TCT 2025

TCT 971: Analysis of Impella and IABP Supported Elective HR-PCI Outcomes and EF Recovery in a Large U.S. Based Electronic Medical Record Database

Presenter: Jason Wollmuth

October 27, 2025

Presentation TCT 2025

Case-in-the-Box Presentation 2: Complex PCI in Cardiogenic Shock ACS with IABP, Haukeland University Hospital, Bergen, Norway

Presenter: Anja Oksnes

October 26, 2025

Presentation TCT 2025

TCT 247: A Systematic Review and Meta-Analysis of Impella Versus IABP in Myocardial Infarction-Related Cardiogenic Shock Revealed Significantly Higher Mortality With the Use of Impella

Presenter: Mohammad Reza Movahed

October 26, 2025

Presentation TCT 2024

TCT 283: Clinical Outcomes of Patients Receiving IABP From the Cardiogenic Shock Working Group: A Comparison of Heart Failure and Myocardial Infarction Related Cardiogenic Shock

Presenter: Arthur Garan

October 29, 2024

Presentation TCT 2024

TCT 1094: Calming the VF Storm With Stellate Ganglion Block and PCI Bifurcation LAD-DG via Tortuous Radial Artery in Inferior Wall STEMI S/P VA ECMO, IABP, IJ Pacemaker

Presenter: Wittawat Wattanasiriporn

October 28, 2024

Presentation TCT 2024

TCT 581: Microaxial Circulatory Flow Pump Supported-PCI Is Associated With Reduced Major Adverse Kidney Events Compared to IABP-Supported PCI in Real-World Settings

Presenter: Amin Polzin

October 28, 2024

Presentation TCT 2023

Coronary Keynote Lecture: When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS

Presenter: Koji Takeda

October 24, 2023

Presentation TCT 2022

When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS

Presenter: Koji Takeda

September 19, 2022

Presentation TCT 2018

IABP in Cardiogenic Shock: Reconciling Clinical Trial Results and Guidelines With Real-World Experience (With Practical-use Recommendations)

Presenter: Cindy L. Grines, E. Magnus Ohman, Richard Smalling

September 22, 2018

Presentation TCT 2018

Major Learnings From IABP-Shock II and CULPRIT-Shock

Presenter: Cindy L. Grines, E. Magnus Ohman, Holger Thiele

September 22, 2018

Presentation TCT 2017

Flash Debate: An IABP Is Really All the Circulatory Support a Good Interventionalist Needs for Almost All Cases of High-Risk PCI!

Presenter: Navin K. Kapur, Jeffrey W. Moses, Gert Richardt

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Presenter: Vladimir Dzavik, Navin K. Kapur, David A Baran

October 31, 2017

Presentation TCT 2017

TCT 4: Prognostic Impact of Nonculprit Chronic Total Occlusions in Infarct-Related Cardiogenic Shock - Results of the Randomized IABP-SHOCK II Trial

Presenter: Rajesh M. Dave, A. Michael Lincoff, Mohammed Saad, MD

October 31, 2017

Presentation TCT 2016

Flash Perspectives on Percutaneous Circulatory Support: An IABP Is Really All a Good Interventionalist Needs!

Presenter: Ulrich P. Jorde, William W. O'Neill, Gert Richardt

October 31, 2016

Presentation TCT 2016

When Mechanical Support During Primary PCI for LV Dysfunction Is Needed: When to Use IABP, Impella, TandemHeart, and/or ECMO

Presenter: Cindy L. Grines, Holger Thiele

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP

Presenter: Simon R. Dixon, Holger Thiele, Susan M Joseph

October 31, 2016

Advertisement

A Prospective, Randomized Clinical Trial of Hemodynamic Support with a Newly Developed pVAD Versus IABP in Patients Undergoing High-Risk Percutaneous Coronary Intervention

Perspective 1: IABP: Not Dead Yet

TCT 282: Clinical Characteristics and Outcome in IABP-Supported Cardiogenic Shock Among Patients Transferred to Tertiary Care Centers

TCT 968: Impella vs. IABP in High-Risk PCI Without Cardiogenic Shock: A Systematic Review and Meta-Analysis of Clinical Outcomes

TCT 971: Analysis of Impella and IABP Supported Elective HR-PCI Outcomes and EF Recovery in a Large U.S. Based Electronic Medical Record Database

Case-in-the-Box Presentation 2: Complex PCI in Cardiogenic Shock ACS with IABP, Haukeland University Hospital, Bergen, Norway

TCT 247: A Systematic Review and Meta-Analysis of Impella Versus IABP in Myocardial Infarction-Related Cardiogenic Shock Revealed Significantly Higher Mortality With the Use of Impella

TCT 283: Clinical Outcomes of Patients Receiving IABP From the Cardiogenic Shock Working Group: A Comparison of Heart Failure and Myocardial Infarction Related Cardiogenic Shock

TCT 1094: Calming the VF Storm With Stellate Ganglion Block and PCI Bifurcation LAD-DG via Tortuous Radial Artery in Inferior Wall STEMI S/P VA ECMO, IABP, IJ Pacemaker

TCT 581: Microaxial Circulatory Flow Pump Supported-PCI Is Associated With Reduced Major Adverse Kidney Events Compared to IABP-Supported PCI in Real-World Settings

Coronary Keynote Lecture: When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS

When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS

IABP in Cardiogenic Shock: Reconciling Clinical Trial Results and Guidelines With Real-World Experience (With Practical-use Recommendations)

Major Learnings From IABP-Shock II and CULPRIT-Shock

Flash Debate: An IABP Is Really All the Circulatory Support a Good Interventionalist Needs for Almost All Cases of High-Risk PCI!

Acute Cardiogenic Shock: The Case for First-line Use of IABP

TCT 4: Prognostic Impact of Nonculprit Chronic Total Occlusions in Infarct-Related Cardiogenic Shock - Results of the Randomized IABP-SHOCK II Trial

Flash Perspectives on Percutaneous Circulatory Support: An IABP Is Really All a Good Interventionalist Needs!

When Mechanical Support During Primary PCI for LV Dysfunction Is Needed: When to Use IABP, Impella, TandemHeart, and/or ECMO

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content